Header Logo

Sheila Dowd

TitleProfessor
InstitutionRush University, Rush Medical College
DepartmentPsychiatry and Behavioral Sciences
Address
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    My Scopus ID is 7101645788.
    My NIH COMMONS name is SDOWD1.

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Taylor CT, Rosenfield D, Dowd SM, Dutcher CD, Hofmann SG, Otto MW, Pollack MH, Smits JAJ. What good are positive emotions for treatment? A replication test of whether trait positive emotionality predicts response to exposure therapy for social anxiety disorder. Behav Res Ther. 2023 12; 171:104436. PMID: 37979218.
      Citations:    
    2. Lubin RE, Fitzgerald HE, Rosenfield D, Carpenter JK, Papini S, Dutcher CD, Dowd SM, Hofmann SG, Pollack MH, Smits JAJ, Otto MW. Using pre-treatment de novo threat conditioning outcomes to predict treatment response to DCS augmentation of exposure-based CBT. J Psychiatr Res. 2023 08; 164:357-363. PMID: 37399757.
      Citations:    
    3. Dutcher CD, Dowd SM, Zalta AK, Taylor DJ, Rosenfield D, Perrone A, Otto MW, Pollack MH, Hofmann SG, Smits JAJ. Sleep quality and outcome of exposure therapy in adults with social anxiety disorder. Depress Anxiety. 2021 11; 38(11):1182-1190. PMID: 34010494.
      Citations:    
    4. Smits JAJ, Pollack MH, Rosenfield D, Otto MW, Dowd S, Carpenter J, Dutcher CD, Lewis EM, Witcraft SM, Papini S, Curtiss J, Andrews L, Kind S, Conroy K, Hofmann SG. Dose Timing of D-Cycloserine to Augment Exposure Therapy for Social Anxiety Disorder: A Randomized Clinical Trial. JAMA Netw Open. 2020 06 01; 3(6):e206777. PMID: 32496566.
      Citations:    
    5. Dowd SM, Zalta AK, Burgess HJ, Adkins EC, Valdespino-Hayden Z, Pollack MH. Double-blind randomized controlled study of the efficacy, safety and tolerability of eszopiclone vs placebo for the treatment of patients with post-traumatic stress disorder and insomnia. World J Psychiatry. 2020 Mar 19; 10(3):21-28. PMID: 32257848.
      Citations:    
    6. Hofmann SG, Papini S, Carpenter JK, Otto MW, Rosenfield D, Dutcher CD, Dowd S, Lewis M, Witcraft S, Pollack MH, Smits JAJ. Effect of d-cycloserine on fear extinction training in adults with social anxiety disorder. PLoS One. 2019; 14(10):e0223729. PMID: 31622374.
      Citations:    
    7. Otto MW, Pollack MH, Dowd SM, Hofmann SG, Pearlson G, Szuhany KL, Gueorguieva R, Krystal JH, Simon NM, Tolin DF. RANDOMIZED TRIAL OF D-CYCLOSERINE ENHANCEMENT OF COGNITIVE-BEHAVIORAL THERAPY FOR PANIC DISORDER. Depress Anxiety. 2016 08; 33(8):737-45. PMID: 27315514.
      Citations:    
    8. Philip NS, Dunner DL, Dowd SM, Aaronson ST, Brock DG, Carpenter LL, Demitrack MA, Hovav S, Janicak PG, George MS. Erratum to "Can Medication Free, Treatment-Resistant, Depressed Patients Who Initially Respond to TMS Be Maintained Off Medications? A Prospective, 12-Month Multisite Randomized Pilot Study" [Brain Stimulation 9 (2016) 251-257]. Brain Stimul. 2016 Jul-Aug; 9(4):639. PMID: 27320180.
      Citations:    
    9. Philip NS, Dunner DL, Dowd SM, Aaronson ST, Brock DG, Carpenter LL, Demitrack MA, Hovav S, Janicak PG, George MS. Can Medication Free, Treatment-Resistant, Depressed Patients Who Initially Respond to TMS Be Maintained Off Medications? A Prospective, 12-Month Multisite Randomized Pilot Study. Brain Stimul. 2016 Mar-Apr; 9(2):251-7. PMID: 26708778.
      Citations:    
    10. Zalta AK, Dowd S, Rosenfield D, Smits JA, Otto MW, Simon NM, Meuret AE, Marques L, Hofmann SG, Pollack MH. Sleep quality predicts treatment outcome in CBT for social anxiety disorder. Depress Anxiety. 2013 Nov; 30(11):1114-20. PMID: 24038728.
      Citations:    
    11. Wall CA, Croarkin PE, Sim LA, Husain MM, Janicak PG, Kozel FA, Emslie GJ, Dowd SM, Sampson SM. Adjunctive use of repetitive transcranial magnetic stimulation in depressed adolescents: a prospective, open pilot study. J Clin Psychiatry. 2011 Sep; 72(9):1263-9. PMID: 21951987.
      Citations:    
    12. Janicak PG, Nahas Z, Lisanby SH, Solvason HB, Sampson SM, McDonald WM, Marangell LB, Rosenquist P, McCall WV, Kimball J, O'Reardon JP, Loo C, Husain MH, Krystal A, Gilmer W, Dowd SM, Demitrack MA, Schatzberg AF. Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study. Brain Stimul. 2010 Oct; 3(4):187-99. PMID: 20965447.
      Citations:    
    13. Janicak PG, Dowd S, Rado J, Welch MJ, Fogg L, O'Reardon J, Avery D, Coffey CE, Sampson S, Boutros N. Repetitive transcranial magnetic stimulation versus electroconvulsive therapy: efficacy of treatment in nonpsychotic patients with depression. Am J Psychiatry. 2007 Jul; 164(7):1118; author reply 1118-9. PMID: 17606665.
      Citations:    
    14. Negrusz A, Bowen AM, Moore CM, Dowd SM, Strong MJ, Janicak PG. Elimination of 7-aminoclonazepam in urine after a single dose of clonazepam. Anal Bioanal Chem. 2003 Aug; 376(8):1198-204. PMID: 12845398.
      Citations:    
    15. Martis B, Alam D, Dowd SM, Hill SK, Sharma RP, Rosen C, Pliskin N, Martin E, Carson V, Janicak PG. Neurocognitive effects of repetitive transcranial magnetic stimulation in severe major depression. Clin Neurophysiol. 2003 Jun; 114(6):1125-32. PMID: 12804681.
      Citations:    
    16. Negrusz A, Bowen AM, Moore CM, Dowd SM, Strong MJ, Janicak PG. Deposition of 7-aminoclonazepam and clonazepam in hair following a single dose of Klonopin. J Anal Toxicol. 2002 Oct; 26(7):471-8. PMID: 12423002.
      Citations:    
    17. Dowd SM, Strong MJ, Janicak PG, Negrusz A. The behavioral and cognitive effects of two benzodiazepines associated with drug-facilitated sexual assault. J Forensic Sci. 2002 Sep; 47(5):1101-7. PMID: 12353555.
      Citations:    
    18. Janicak PG, Dowd SM, Martis B, Alam D, Beedle D, Krasuski J, Strong MJ, Sharma R, Rosen C, Viana M. Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for major depression: preliminary results of a randomized trial. Biol Psychiatry. 2002 Apr 15; 51(8):659-67. PMID: 11955466.
      Citations:    
    19. Janicak PG, Easton MS, Comaty JE, Dowd S, Davis JM. Efficacy of ECT in Psychotic and Nonpsychotic Depression. Convuls Ther. 1989; 5(4):314-320. PMID: 11941029.
      Citations:    
    Dowd's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (78)
    Explore
    _
    Co-Authors (2)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _